| EP2142515 - NITROVINYL-DIAMINE DERIVATIVES AS GLUTAMINYL CYCLASE INHIBITORS [Right-click to bookmark this link] | |||
| Former [2010/02] | NOVEL INHIBITORS | ||
| [2013/42] | Status | No opposition filed within time limit Status updated on 30.01.2015 Database last updated on 11.04.2026 | Most recent event Tooltip | 15.07.2016 | Lapse of the patent in a contracting state New state(s): TR | published on 17.08.2016 [2016/33] | Applicant(s) | For all designated states Probiodrug AG Weinbergweg 22 06120 Halle/Saale / DE | [2014/13] |
| Former [2010/02] | For all designated states Probiodrug AG Weinbergweg 22 06120 Halle/Saale / DE | Inventor(s) | 01 /
BUCHHOLZ, Mirko Brandenburger Strasse 6 06114 Halle/Saale / DE | 02 /
HEISER, Ulrich Franz-Schubert-Strasse 5 06108 Halle/Saale / DE | 03 /
HAMANN, Antje Ahornring 45 06184 Dieskau / DE | [2010/02] | Representative(s) | Hoffmann, Matthias, et al Maikowski & Ninnemann Patentanwälte Kurfürstendamm 54-55 10707 Berlin / DE | [2012/29] |
| Former [2010/02] | Hoffmann, Matthias Probiodrug AG Weinbergweg 22 06120 Halle/Saale / DE | Application number, filing date | 08736366.9 | 18.04.2008 | [2010/02] | WO2008EP54717 | Priority number, date | US20070912535P | 18.04.2007 Original published format: US 912535 P | [2010/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008128987 | Date: | 30.10.2008 | Language: | EN | [2008/44] | Type: | A1 Application with search report | No.: | EP2142515 | Date: | 13.01.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.10.2008 takes the place of the publication of the European patent application. | [2010/02] | Type: | B1 Patent specification | No.: | EP2142515 | Date: | 26.03.2014 | Language: | EN | [2014/13] | Search report(s) | International search report - published on: | EP | 30.10.2008 | Classification | IPC: | C07D233/54, A61K31/4164, A61P25/00, C07D405/12 | [2010/02] | CPC: |
C07D233/61 (EP,US);
A61P1/04 (EP);
A61P1/18 (EP);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P35/00 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P7/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/02] | Title | German: | NITROVINYL-DIAMIN DERIVATE ALS GLUTAMINYL CYCLASE HEMMER | [2013/44] | English: | NITROVINYL-DIAMINE DERIVATIVES AS GLUTAMINYL CYCLASE INHIBITORS | [2013/42] | French: | DERIVES DE NITROVINYL-DIAMINE EN TANT QUE INHIBITEURS DE LA GLUTAMINYL-CYCLASE | [2013/44] |
| Former [2010/02] | NEUE INHIBITOREN | ||
| Former [2010/02] | NOVEL INHIBITORS | ||
| Former [2010/02] | NOUVEAUX INHIBITEURS | Entry into regional phase | 04.11.2009 | National basic fee paid | 04.11.2009 | Designation fee(s) paid | 04.11.2009 | Examination fee paid | Examination procedure | 04.11.2009 | Amendment by applicant (claims and/or description) | 04.11.2009 | Examination requested [2010/02] | 15.04.2013 | Despatch of a communication from the examining division (Time limit: M04) | 20.08.2013 | Reply to a communication from the examining division | 17.10.2013 | Communication of intention to grant the patent | 17.02.2014 | Fee for grant paid | 17.02.2014 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.04.2013 | Opposition(s) | 06.01.2015 | No opposition filed within time limit [2015/10] | Fees paid | Renewal fee | 24.03.2010 | Renewal fee patent year 03 | 11.04.2011 | Renewal fee patent year 04 | 16.03.2012 | Renewal fee patent year 05 | 12.04.2013 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 18.04.2008 | CY | 26.03.2014 | CZ | 26.03.2014 | EE | 26.03.2014 | FI | 26.03.2014 | HR | 26.03.2014 | LT | 26.03.2014 | LV | 26.03.2014 | MT | 26.03.2014 | NL | 26.03.2014 | PL | 26.03.2014 | RO | 26.03.2014 | SI | 26.03.2014 | SK | 26.03.2014 | TR | 26.03.2014 | BG | 26.06.2014 | NO | 26.06.2014 | GR | 27.06.2014 | IS | 26.07.2014 | PT | 28.07.2014 | [2016/33] |
| Former [2016/32] | HU | 18.04.2008 | |
| CY | 26.03.2014 | ||
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| MT | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SI | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| GR | 27.06.2014 | ||
| IS | 26.07.2014 | ||
| PT | 28.07.2014 | ||
| Former [2016/28] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| MT | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SI | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| GR | 27.06.2014 | ||
| IS | 26.07.2014 | ||
| PT | 28.07.2014 | ||
| Former [2016/16] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| MT | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SI | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| IS | 26.07.2014 | ||
| PT | 28.07.2014 | ||
| Former [2015/36] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SI | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| IS | 26.07.2014 | ||
| PT | 28.07.2014 | ||
| Former [2015/02] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| IS | 26.07.2014 | ||
| PT | 28.07.2014 | ||
| Former [2014/50] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| NL | 26.03.2014 | ||
| PL | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| SK | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| IS | 26.07.2014 | ||
| Former [2014/49] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| RO | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| IS | 26.07.2014 | ||
| Former [2014/48] | CY | 26.03.2014 | |
| CZ | 26.03.2014 | ||
| EE | 26.03.2014 | ||
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| BG | 26.06.2014 | ||
| NO | 26.06.2014 | ||
| Former [2014/47] | CY | 26.03.2014 | |
| FI | 26.03.2014 | ||
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| NO | 26.06.2014 | ||
| Former [2014/41] | FI | 26.03.2014 | |
| HR | 26.03.2014 | ||
| LT | 26.03.2014 | ||
| LV | 26.03.2014 | ||
| NO | 26.06.2014 | ||
| Former [2014/37] | FI | 26.03.2014 | |
| LT | 26.03.2014 | ||
| NO | 26.06.2014 | ||
| Former [2014/36] | LT | 26.03.2014 | |
| NO | 26.06.2014 | Cited in | International search | [Y] BUCHHOLZ MIRKO ET AL: "The first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship", JOURNAL OF MEDICINAL CHEMISTRY, USAMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 49, no. 2, 1 January 2006 (2006-01-01), pages 664 - 677, XP002462493, ISSN: 0022-2623 [Y] 1-24 * page 665 - page 666 * DOI: http://dx.doi.org/10.1021/jm050756e |